Neurocrine Biosciences
NBIX
#1542
Rank
C$15.83 B
Marketcap
$158.85
Share price
1.23%
Change (1 day)
-16.81%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Earnings for Neurocrine Biosciences (NBIX)

Earnings in 2024 (TTM): C$0.70 Billion

According to Neurocrine Biosciences 's latest financial reports the company's current earnings are C$2.35 Billion. , an increase over its 2023 earnings that were of C$0.44 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Neurocrine Biosciences from 1996 to 2024

Annual earnings

Year Earnings Change
2024 C$0.73 B64.57%
2023 C$0.44 B41.13%
2022 C$0.31 B73.74%
2021 C$0.18 B-8.82%
2020 C$0.20 B77.78%
2019 C$0.11 B49.83%
2018 C$75.4 M-142.57%
2017 -C$0.18 Billion-14.73%
2016 -C$0.21 Billion53.15%
2015 -C$0.14 Billion46.25%
2014 -C$92.74 Million29.66%
2013 -C$71.53 Million-3530.8%
2012 C$2.08 M-95.73%
2011 C$48.83 M
2009 -C$68.66 Million-45.38%
2008 -C$0.13 Billion-58.87%
2007 -C$0.31 Billion87.3%
2006 -C$0.17 Billion351.97%
2005 -C$36.1 Million-52.09%
2004 -C$75.35 Million-10.98%
2003 -C$84.64 Million
2001 -C$63.18 Million
1999 -C$28.5 Million108.32%
1998 -C$13.68 Million
1996 C$4.17 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
C$27.67 M-96.26%๐Ÿ‡บ๐Ÿ‡ธ USA
C$2.24 B 203.20%๐Ÿ‡ฌ๐Ÿ‡ง UK
-C$38.79 Million-105.25%๐Ÿ‡บ๐Ÿ‡ธ USA
C$18.25 B 2,370.37%๐Ÿ‡บ๐Ÿ‡ธ USA
C$5.35 B 623.94%๐Ÿ‡บ๐Ÿ‡ธ USA
C$9.99 B 1,252.62%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$10.81 Million-101.46%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$60.13 Million-108.14%๐Ÿ‡บ๐Ÿ‡ธ USA